345 related articles for article (PubMed ID: 10909973)
1. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
Skoglund G; Hussain MA; Holz GG
Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220.
Chepurny OG; Hussain MA; Holz GG
Endocrinology; 2002 Jun; 143(6):2303-13. PubMed ID: 12021195
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG; Holz GG
Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
Kemp DM; Habener JF
Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
[TBL] [Abstract][Full Text] [Related]
5. Insulinotropic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase.
Kemp DM; Habener JF
Endocrinology; 2001 Mar; 142(3):1179-87. PubMed ID: 11181533
[TBL] [Abstract][Full Text] [Related]
6. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Lawrence MC; Bhatt HS; Easom RA
Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
Wang X; Zhou J; Doyle ME; Egan JM
Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
[TBL] [Abstract][Full Text] [Related]
9. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
[TBL] [Abstract][Full Text] [Related]
10. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
Widmann C; Dolci W; Thorens B
Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
12. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
13. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
Hui H; Yu R; Bousquet C; Perfetti R
Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.
Bode HP; Moormann B; Dabew R; Göke B
Endocrinology; 1999 Sep; 140(9):3919-27. PubMed ID: 10465260
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
Calin-Jageman IE; Wang J; Bannon MJ
J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
Hui H; Nourparvar A; Zhao X; Perfetti R
Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element.
Kim MJ; Kang JH; Park YG; Ryu GR; Ko SH; Jeong IK; Koh KH; Rhie DJ; Yoon SH; Hahn SJ; Kim MS; Jo YH
J Endocrinol; 2006 Mar; 188(3):623-33. PubMed ID: 16522741
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
Stark A; Mentlein R
Regul Pept; 2002 Oct; 108(2-3):97-102. PubMed ID: 12220732
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
